Annual FCF
-$397.34 M
+$39.56 M+9.05%
December 31, 2023
Summary
- As of February 12, 2025, IBRX annual free cash flow is -$397.34 million, with the most recent change of +$39.56 million (+9.05%) on December 31, 2023.
- During the last 3 years, IBRX annual FCF has fallen by -$223.95 million (-129.16%).
- IBRX annual FCF is now -154.06% below its all-time high of -$156.40 million, reached on December 31, 2019.
Performance
IBRX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$101.56 M
-$484.00 K-0.48%
September 30, 2024
Summary
- As of February 12, 2025, IBRX quarterly free cash flow is -$101.56 million, with the most recent change of -$484.00 thousand (-0.48%) on September 30, 2024.
- Over the past year, IBRX quarterly FCF has dropped by -$484.00 thousand (-0.48%).
- IBRX quarterly FCF is now -223.20% below its all-time high of -$31.42 million, reached on March 31, 2020.
Performance
IBRX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$434.10 M
-$8.48 M-1.99%
September 30, 2024
Summary
- As of February 12, 2025, IBRX TTM free cash flow is -$434.10 million, with the most recent change of -$8.48 million (-1.99%) on September 30, 2024.
- Over the past year, IBRX TTM FCF has dropped by -$8.48 million (-1.99%).
- IBRX TTM FCF is now -1281.50% below its all-time high of -$31.42 million, reached on March 31, 2020.
Performance
IBRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
IBRX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.1% | -0.5% | -2.0% |
| 3 y3 years | -129.2% | -15.0% | -12.1% |
| 5 y5 years | -154.1% | -15.0% | -12.1% |
IBRX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -29.0% | +9.1% | -23.8% | +17.8% | -41.0% | +0.6% |
| 5 y | 5-year | -154.1% | +9.1% | -223.2% | +17.8% | -1281.5% | +0.6% |
| alltime | all time | -154.1% | +9.1% | -223.2% | +17.8% | -1281.5% | +0.6% |
ImmunityBio Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$101.56 M(+0.5%) | -$434.10 M(+2.0%) |
| Jun 2024 | - | -$101.07 M(-6.6%) | -$425.62 M(+3.1%) |
| Mar 2024 | - | -$108.24 M(-12.2%) | -$412.85 M(+3.9%) |
| Dec 2023 | -$397.34 M(-9.1%) | -$123.23 M(+32.4%) | -$397.34 M(+3.5%) |
| Sep 2023 | - | -$93.08 M(+5.4%) | -$383.77 M(-0.9%) |
| Jun 2023 | - | -$88.30 M(-4.8%) | -$387.23 M(-4.7%) |
| Mar 2023 | - | -$92.74 M(-15.4%) | -$406.13 M(-7.0%) |
| Dec 2022 | -$436.90 M | -$109.66 M(+13.6%) | -$436.90 M(+6.7%) |
| Sep 2022 | - | -$96.53 M(-9.9%) | -$409.28 M(+4.0%) |
| Jun 2022 | - | -$107.20 M(-13.2%) | -$393.50 M(+8.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$123.51 M(+50.5%) | -$363.94 M(+18.2%) |
| Dec 2021 | -$307.98 M(+77.6%) | -$82.04 M(+1.6%) | -$307.98 M(+8.9%) |
| Sep 2021 | - | -$80.75 M(+4.0%) | -$282.85 M(+17.3%) |
| Jun 2021 | - | -$77.64 M(+14.9%) | -$241.13 M(+15.1%) |
| Mar 2021 | - | -$67.55 M(+18.7%) | -$209.52 M(+20.8%) |
| Dec 2020 | -$173.39 M(+10.9%) | -$56.91 M(+45.8%) | -$173.39 M(+48.9%) |
| Sep 2020 | - | -$39.03 M(-15.2%) | -$116.49 M(+50.4%) |
| Jun 2020 | - | -$46.03 M(+46.5%) | -$77.45 M(+146.5%) |
| Mar 2020 | - | -$31.42 M | -$31.42 M |
| Dec 2019 | -$156.40 M | - | - |
FAQ
- What is ImmunityBio annual free cash flow?
- What is the all time high annual FCF for ImmunityBio?
- What is ImmunityBio annual FCF year-on-year change?
- What is ImmunityBio quarterly free cash flow?
- What is the all time high quarterly FCF for ImmunityBio?
- What is ImmunityBio quarterly FCF year-on-year change?
- What is ImmunityBio TTM free cash flow?
- What is the all time high TTM FCF for ImmunityBio?
- What is ImmunityBio TTM FCF year-on-year change?
What is ImmunityBio annual free cash flow?
The current annual FCF of IBRX is -$397.34 M
What is the all time high annual FCF for ImmunityBio?
ImmunityBio all-time high annual free cash flow is -$156.40 M
What is ImmunityBio annual FCF year-on-year change?
Over the past year, IBRX annual free cash flow has changed by +$39.56 M (+9.05%)
What is ImmunityBio quarterly free cash flow?
The current quarterly FCF of IBRX is -$101.56 M
What is the all time high quarterly FCF for ImmunityBio?
ImmunityBio all-time high quarterly free cash flow is -$31.42 M
What is ImmunityBio quarterly FCF year-on-year change?
Over the past year, IBRX quarterly free cash flow has changed by -$484.00 K (-0.48%)
What is ImmunityBio TTM free cash flow?
The current TTM FCF of IBRX is -$434.10 M
What is the all time high TTM FCF for ImmunityBio?
ImmunityBio all-time high TTM free cash flow is -$31.42 M
What is ImmunityBio TTM FCF year-on-year change?
Over the past year, IBRX TTM free cash flow has changed by -$8.48 M (-1.99%)